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Abstract
Background: The English NHS publishes hospital performance indicators based on average post-
operative EQ-5D index scores after hip replacement surgery to inform prospective patients choices 
of hospital. Unidimensional index scores are derived from multidimensional health-related quality of 
life data using preference weights estimated from a sample of the UK general population. This raises 
normative concerns if general population preferences differ from those of the patients that are to be 
informed. This study explores how the source of valuation affects hospital performance estimates.
Methods: Four different value sets reflecting source of valuation (general population vs. patients), 
valuation technique (visual analogue scale (VAS) vs. time trade-off (TTO)) and experience with health 
states (currently experienced vs experimentally estimated) were used to derive and compare 
performance estimates for 243 hospitals. Two value sets were newly estimated from EQ-5D-3L data 
on 122,921 hip replacement patients and 3,381 members of the UK general public. Changes in 
hospital ranking (nationally) and performance outlier status (nationally; amongst patients five 
closest hospitals) were compared across valuations. 
Results: National rankings are stable under different valuations (rank correlations > 0.92). Twenty-
three (9.5%) hospitals change outlier status when using patient VAS valuations instead of general 
population TTO valuations, the current approach. Outlier status also changes substantially at local 
level. This is explained mostly by the valuation technique, not the source of valuations or experience 
with the health states. 
Limitations: No patient TTO valuations were available. Effect of value set characteristics could only 
be established through indirect comparisons.
Conclusion: Different value sets may lead to prospective patients choosing different hospitals. 
Normative concerns about the use of general population valuations are not supported by empirical 
evidence based on VAS valuations.  
Page 2 of 49
http://mc.manuscriptcentral.com/mdm
Medical Decision Making
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
3
1 Introduction
Patients in the English National Health Service (NHS) have the right to choose among all qualified 
hospital providers for treatments that are deemed clinically appropriate and are publicly funded. To 
inform patients [] exercising choice (p.6)[1] about the quality of care they are likely to receive, 
the English NHS routinely collects multidimensional health-related quality of life (HRQoL) data from 
patients before and after undergoing planned hip and knee replacement surgical as part of the 
national patient-reported outcome measures (PROMs) programme. These data are then used to 
benchmark hospitals and calculate performance indicators in the form of case-mix adjusted average 
post-operative HRQoL, expressed as unidimensional composite scores, which are made publicly 
available on a regular basis.[2, 3] 
A normative question, and the focus of this paper, is how to aggregate the multidimensional HRQoL 
data into unidimensional (single number) scores for the purpose of hospital performance 
assessment and public reporting. The PROMs programme collects HRQoL data using a generic health 
measurement instrument, the EQ-5D-3L[4], which comprises both a direct and indirect measure of a 
patients health state. The direct measure, the EQ VAS, asks patients to provide a summary 
assessment of their HRQoL by marking a position on a visual analogue scale (VAS) ranging from 0 to 
100, where the endpoints reflect the best and worst health states imaginable. The indirect measure 
uses the EQ-5D-3L descriptive system, where patients are asked to describe their current health 
status according to five dimensions of health (mobility, self-care, usual activities, pain & discomfort 
and anxiety & depression), each of which can be assigned one of three severity levels (essentially no, 
some or extreme problems). The resulting health profile data are aggregated into unidimensional 
composite (index) scores using preference estimates of the UK general population[5], rather than 
of those prospective patients the PROMs programme seeks to inform. Previous research has shown 
many cases where preference estimates derived from specific patient populations differ 
systematically from those derived from the general population[6-10] although some studies find no 
differences [11, 12]. The current practice therefore raises normative concerns and could be 
inconsistent with the notion of patient sovereignty if it leads to a mismatch between the decisions 
patients make based on official published data, and those they would have made had the 
information reflected their own preferences more closely. 
Ideally, the reported hospital performance should reflect prospective patients individual 
preferences over relevant health states. However, the elicitation of personal preference functions is 
a complex and time-consuming task[13] and has therefore not (yet) found widespread adoption in 
the public reporting of hospital performance. Furthermore, it would imply the need to re-calculate 
public reports for each prospective patient based on their individual preferences, ruling out static 
performance reports (e.g. rankings published in newspapers) that are common currently. A 
pragmatic solution, that avoids both issues, is to develop a value set based on preferences elicited 
from a sample of patients. Such value sets are likely to reflect the preferences of prospective 
patients more closely than a general population value set since they are obtained from a sample of 
individuals with a similar age-sex structure, clinical condition, adaptation to their condition, and 
expectations of future health. At the same time, it would enable the calculation of EQ-5D index 
scores and, hence, unidimensional hospital performance indicators that could be presented 
alongside detailed dimension-by-dimension estimates[14] if desired. 
In this paper we test whether the use of patient or general population valuations generates different 
hospital performance estimates for hip replacement surgery in the English NHS. We are not aware of 
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4
a UK-based patient value set that mirrors the currently used general population value set in terms of 
two other important aspects, namely respondents experience of the health state to be valued as 
well as the valuation technique employed. This precludes a direct test of the effect of the source of 
valuation on hospital performance estimates. Instead, we compare hospital performance estimates 
generated under four published and newly-estimated value sets, out of eight possible combinations 
of these value set attributes. This allows us to vary one aspect at a time, holding the other two 
constant. The results of this indirect comparison help to demonstrate the practical implications of 
the normative argument about the source of health state valuations in the context of informing 
prospective patients about where to have surgery.
2 Valuation of health states
Amongst the desirable properties of a measure of the value of health is that it should unambiguously 
indicate whether a given health state, as defined by a multidimensional HRQoL profile, is better 
than, worse than, or equivalent to another health state. This property is most usually achieved by 
aggregating HRQoL data into a single number that represents the value of a health state by means of 
a set of preference weights. By convention, the value of a health state lies on a scale where 1 
represents health which as good as possible, and 0 represents health that is either as poor as 
possible or is equivalent to being dead. The latter allows for health states worse than dead with 
values below 0.
Any attempt to value health in this way requires consideration of the following questions: (1) what is 
being valued; (2) whose values are being sought; and (3) what technique is being used to obtain the 
values? These are each briefly summarised below with interested readers being referred to detailed 
discussions elsewhere.[15-17]
2.1 What is being valued
Health state valuations are obtained as part of elicitation tasks.  In these, participants may be asked 
to value their own health, as experienced either currently or in the past, or a set of health states that 
they may not be currently experiencing. For the latter, they are usually asked to value a stylised 
description of health, which may take the form of a health state profile comprising a series of 
dimensions and severity levels defined by the descriptive system of a PROM instrument, such as the 
EQ-5D. Such profiles are often described as hypothetical, but this is misleading because they are 
intended to reflect real health states and therefore plausible ways in which someone might self-
report their health using the instrument. Since in most cases respondents will neither be 
experiencing or ever have experienced a health state described in the profile, they would need to 
imagine living in that health state in order to evaluate it. We can therefore regard these as their 
estimate of how they would value the health state if they were experiencing it.
2.2 Whose values are being sought
Health state valuations can be obtained from selected subgroups, such as patients with a given 
medical condition, or a sample of the general population.[16, 18, 19] Both approaches have merit, 
although advocates tend to argue their case on different grounds. Those in favour of using patient 
valuations typically point out that patients have N	 experience of health states and therefore 
do not need to imagine the impact of an unfamiliar health state on their HRQoL.[20, 21] A common 
finding in the published literature - that valuations derived from specific patient populations tend to 
be higher than those elicited from the general population - has been attributed to patients adapting 
to their impaired health state over time and/or providing a more accurate assessment of the health 
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state based on their lived experience.[6, 7, 21] Conversely, proponents of general population 
valuations typically argue their case not on the grounds of validity but based on the intended use of 
such valuations to inform resource allocation decision in collectively funded health services, where 
decisions should reflect the preferences of the general population paying into the system.[18]
It is important to note that what is being valued and by whom are two separate issues. Patients may 
be asked to value health states that can occur as a result of their medical condition and which they 
may be able to imagine living in, but which they have not (yet) experienced themselves. Equally, the 
general population can be asked to value their currently experienced health state.[22]
2.3 What elicitation technique is being used
There are a number of techniques for valuing health states such as VAS and time trade-off (TTO).[23] 
The VAS involves rating the health state on a scale with imposed interval properties and well-defined 
endpoints, conventionally 0 and 100 (which in the EQ VAS represent worst and best imaginable 
health, respectively). TTO involves making a series of choices between living for a fixed amount of 
time in the profile under evaluation and a shorter, variable amount of time in full health, where the 
point at which respondents are indifferent is used to infer valuations. TTO has become the method 
most often recommended for the generation of values. The two methods have different 
assumptions underpinning them and are subject to different types of framing effects, for example 
VAS valuations are known to be subject to end-of-scale aversion [24] whereas respondents time 
preference can have an effect on TTO valuations [25, 26]. VAS exercises are widely considered to be 
relatively simple and feasible to complete.[27] Previous research has shown that VAS and TTO yield 
different results.[28]
3 Methods
3.1 Data 
We analyse EQ-5D-3L data from two independent samples. The first consists of 272,445 NHS-funded 
total hip replacement (THR) patients aged 15 years or over who had primary surgery in public or 
private hospitals in England between April 2012 and March 2016, collected as part of the English 
national PROMs programme[1]. Patients completed a paper questionnaire shortly before and six 
months after having surgery, containing the EQ-5D-3L, a condition-specific measure (the Oxford Hip 
Score) and other questions about their condition and treatment. The pre-operative questionnaire 
was administered by hospital staff at admission or the last outpatient appointment preceding 
admission and forwarded to a central data processor. The post-operative questionnaire was mailed 
directly to the patients home address. Returned questionnaires were linked to administrative 
hospital records from the Hospital Episode Statistics (HES) database through a probabilistic matching 
algorithm. HES provides information on patients age, place of residence, provider of care, and 
whether the surgery was a revision of a previous THR. Further details about the PROM data 
collection procedure are provided elsewhere.[29, 30] We excluded patients for whom pre- or post-
operative responses were missing, either in part or completely, or where questionnaires could not 
be linked to HES. The sample used to estimate the patient value set in this study included 122,921 
patients, which corresponds to 45.1% of all THR patients that were eligible to participate in the 
PROMs survey. Excluded patients were on average slightly younger and more likely to be female 
(Appendix Table 1). The linked HES-PROMs dataset was provided by NHS Digital.
The second sample consists of 3,381 randomly selected members of the UK general public that took 
part in the Measurement and Valuation of Health (MVH) study.[31] Each of the participants were 
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6
asked as part of face-to-face interviews to rate their own health status using the EQ-5D-3L 
questionnaire and to value 8 of 42 stylised health states using TTO[32] and VAS. The valuation data 
were used to derive a TTO based value set known as the MVH-A1 [5], but which we label the GP-
TTO-VAL, and a VAS based value set known as the MVH-A3, but which we label the GP-VAS-VAL 
(Table 1).[31] The former is used in the official calculation of the hospital performance estimates 
reported to the public. Both value sets are anchored at 1 (full health) and 0 (dead), with scores 
below 0 indicating states considered worse than being dead. The MVH dataset was provided by the 
UK Data Services.
3.2 Estimation of experience-based value sets
A patient, current health VAS value set, which we label the PAT-VAS-OWN, was derived from the 
national PROMs dataset by regressing patient-reported EQ VAS scores on variables representing the 
levels within each dimension of the EQ-5D descriptive system, using Ordinary Least Squares. The 
regression model underpinning the MHV value sets include dummy variables for the main effects, a 
constant term reflecting any deviation from full health, and an N3 term indicating extreme problems 
(level 3) on any dimension.[5] To ensure comparability with these, we used the same specification. 
We also estimated more saturated models allowing for pairwise interactions between dimensions at 
level 2 and 3, but found these added little to overall fit (results available on request). 
The PAT-VAS-OWN value set was estimated on data for the period April 2012 to March 2015, leaving 
one year of data to assess the impact of the value set on hospital rankings (see Section 2.4). It has 
been observed that patients valuations of the same description of their health state may change from 
pre- to post-surgery, which may lead to inconsistencies when estimating patient-based value sets.[33] 
We focus our analysis on pre-operative survey responses since these are more likely to reflect 
patients preferences at the point in time when a choice is to be made.
We also estimated a general population, current health VAS value set, which we label the GP-VAS-
OWN, using the MVH study participants EQ VAS and self-classifier responses and the same 
modelling structure as for the PAT-VAS-OWN value set. 
Table 1 summarises the characteristics of the four value sets that we compared.
All standard errors are robust to heteroscedasticity and, in the case of the PAT-VAS-OWN value set, 
are clustered at hospital level. All computations were performed in Stata 14 (StataCorp LP, College 
Station, TX).
3.3 Deriving hospital performance estimates
Hospital performance assessment aims to identify the systematic contribution that providers make 
to their patients health outcomes.[34] To allow for fair comparisons these assessments need to 
adjust for differences in hospital case-mix and sampling uncertainty.
Our analysis followed the published adjustment methodology of NHS England[35], in which the case-
mix adjusted performance  of hospital  is estimated as = 	
= 1
 
= 1( )
where  is the observed post-operative index score for patient  and  is the expected  = 1,,
 
post-operative index score for the same patient given their observable characteristics. 
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7
The expected post-operative index score is based on the official case-mix adjustment methodology 
developed by NHS England[35]. The adjustment takes account of age, gender, ethnicity, living 
arrangements, the income deprivation profile of the patients local small areas of residence (Lower-
Layer Super Output Area (LSOA)) as approximated by the 2010 Index of Deprivation[36], main 
diagnosis and comorbid conditions, whether patients lived alone, whether they required assistance 
when filling in the PROMs questionnaire or considered themselves to be disabled, the duration of 
symptoms, as well as their pre-operative EQ-5D index score. We estimate the case-mix adjustment 
model separately for each of the four value sets using data from April 2012 to March 2014.
To account for sampling uncertainty in performance scores we follow standard practice[37-39] in the 
NHS and calculated z-score statistics for each hospital as= ( ))
where  indicates statistically significant divergent performance from the national average > 1.96
at the 5% level. Hospitals with  were deemed to perform well if  and poorly > 1.96 > 0
otherwise. Performance estimates that were not statistically significantly different from the national 
average were deemed average. This approach is consistent with the simplified pictorial display used 
to communicate performance information (green, blue and red buttons to denote good, average 
and poor performance) by NHS choices[2] and other hospital comparison websites[3].
3.4 Assessing the impact of different EQ-5D value sets on hospital 
performance estimates
We assessed the impact of different value sets on hospital performance estimates for the period 
between April 2015 and March 2016 through a series of head-to-head comparisons. For each hospital, 
we compared their performance status (i.e. whether they were judged to perform well, poorly, or 
average) under different value sets and quantified discrepancies. The strength of association between 
hospital performance rankings generated with different value sets was measured using Spearmans 
rank correlation coefficient . 
One motivation for considering patient valuations in assessing hospital performance is the desire to 
provide prospective patients with information that will inform their choice of hospital. Yet, most 
patients are unwilling to travel far for healthcare treatment[40-42], with a recent study[43] 
suggesting that over 92% of THR patients in the English NHS chose to attend one of their five closest 
hospitals in the period 2010 to 2012. We therefore also explored the impact of value sets at the local 
level; for each patient, we assessed how many of their five closest hospitals would be flagged as 
performing well or poorly under the different value sets. This choice set was determined by the 
straight-line distance between the centroid of the patients LSOA of residence and the hospitals 
postcodes.[43] 
4 Results
4.1 Descriptive statistics
Table 2 reports descriptive statistics of the data samples. Patients in the national PROMs programme 
sample were, on average, 68 years old and 58.7% were female. Most patients had suffered from 
joint-related symptoms for 1 to 5 years prior to surgery. The average improvement in HRQoL six 
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months after surgery was equivalent to an increase of 0.43 value points (from 0.37 to 0.80) (MVH-A1 
value set), and patients overall assessment of their health as measured by the EQ VAS increased by 
12 points (from 65 to 77). Patients described their pre-operative HRQoL using 148 of the 243 
possible EQ-5D-3L health states. The relative frequency of these health states was consistent with 
the severity of the conditions that require major joint replacement. Over 46% of patients reported 
extreme limitation (i.e. level 3 problems) on at least one HRQoL dimension before surgery, and >2% 
reported extreme limitations on three or more dimensions.
Unsurprisingly, MVH study participants reported better health on average than the patient sample, 
both pre- and post-surgery.  They were, on average, significantly younger (mean age = 47.9 years) 
than the patient population but showed a similar sex split (56.7% female). Participants described 
their health using 77 of the 243 EQ-5D-3L health states, with 4.8% of participants having at least one 
extreme limitation on any of the five health dimensions. The average VAS score was 82.5 and the 
average EQ-5D value based on the GP-TTO-VAL value set was 0.86.
4.2 Value sets 
Table 3 reports the estimated PAT-VAS-OWN and GP-VAS-OWN value sets alongside the published 
GP-TTO-VAL and GP-VAS-VAL value sets. Coefficient estimates represent decrements associated with 
some or extreme limitations on a given health dimension. The constant and the N3 term reflect 
global decrements that are applied in the presence of any limitations on any health dimension and 
at least one extreme limitation on any health dimension, respectively. 
Figure 1 shows the values generated by the different value sets for the 42 stylised health states 
valued in the MVH study.
Both PAT-VAS-OWN and GP-VAS-OWN value sets were found to be internally consistent, i.e. more 
severe limitations are associated with larger decrements for each dimension. Patients assign 
approximately equal or smaller decrements to health problems on a given dimension than the 
general public, but they attach a larger global decrement to the presence of any health problems as 
reflected in the coefficient on the constant term. Differences are more pronounced on level 3 
decrements than level 2 decrements, thus generating a wider spread of index scores across the four 
value sets for health states for which respondents reported at least one extreme problem. These 
results are consistent with previous evidence from other patient populations.[7, 44] It should be 
noted that because of the smaller sample size, the GP-VAS-OWN data has sparse observations in 
some of the levels within dimensions, particularly Mobility Level 3, which means that the coefficient 
estimates have very large standard errors.
Table 4 reports descriptive statistics of the pre- and post-operative index scores reported at patient 
level (mean, SD) as well as the range of hospital average scores calculated using the four value sets. 
Differences in average index scores are more pronounced prior to surgery than afterwards, which 
reflects the low number of patients reporting any extreme problems after surgery. The two value 
sets based on direct valuations of own, currently experienced health (GP-VAS-OWN, PAT-VAS-OWN) 
generate, on average, higher index scores as well as a smaller spread of hospital average index 
scores that are relevant for performance assessment. Histograms of case-mix adjusted hospital 
scores are presented in the online appendix.
4.3 Impact on judgements about hospital performance
Figure 2 presents scatter plots of hospital z-scores derived under different EQ-5D value sets. Each 
scatter point represents one hospital, with dashed lines indicating the lower and upper boundaries 
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9
at which performance estimates are deemed to be statistically significantly different from the 
national average. Performance estimates that would lead to differential judgement under the two 
value sets being compared are highlighted as diamonds (significant under the first but not the 
second value set) or squares (vice versa). 
The GP-TTO-VAL and PAT-VAS-OWN value sets generate performance estimates that are highly 
correlated (  = 0.92) (Figure 2, Panel A). Despite this, the change in value set has a non-negligible 
impact on how individual hospitals are deemed to perform, with patient valuations leading to 
changes in outlier status for 23 hospitals in total (9.5% of 243), of which 6 (2.5%) are no longer 
identified as performing poorly, 10 (4.1%) are no longer identified as performing well, and seven 
different hospitals now appear to perform well (2.9%). At the local level, 1% fewer patients (44% vs 
45% of N=65,278) receiving care between April 2015 and March 2016 would have found at least one 
well performing hospital within their five closest hospitals if performance estimates had been 
derived using the PAT-VAS-OWN value set rather than the GP-TTO-VAL (Figure 3). In contrast, 
patients would have been 10% more likely (34% vs 24%) to find at least one local hospital deemed to 
perform poorly if performance estimates had been derived using the PAT-VAS-OWN value set. 
Overall, at least one performance assessment for their five closest hospitals would have been 
different for 8.6% of patients receiving care between April 2015 and March 2016. 
To further explore the reasons for this divergence, we compared hospital performance estimates 
derived varying one value set design characteristic (i.e. source of valuation, valuation technique, or 
experience with health state) while holding the others constant (Figure 2, Panels B-D). The results of 
this marginal analysis suggest that neither the source of valuation nor the level of experience with a 
health state drive the observed differences in hospital performance classifications. Instead, these 
differences can be explained nearly entirely by the choice of valuation technique employed, with 
Panel B showing many more changes in outlier status than Panel C and D.
5 Discussion
There is a strong normative rationale for using patient values to aggregate multidimensional HRQoL 
instruments when developing hospital performance indicators to inform prospective patients 
choices of hospital. However, the standard practice in the English NHS has been to publish hospital 
performance indicators based on EQ-5D scores aggregated using general public values. The present 
study explores whether this practice may be distorting patients' choice of hospital for hip 
replacement surgery given that there is some evidence of discrepancies between patient and 
general public values. We find a larger number of hospitals are deemed to perform poorly when a 
patient VAS tariff (PAT-VAS-OWN) is used compared to when the UK general population TTO tariff 
(GP-TTO-VAL) is used. Conversely, we find only slightly fewer hospitals are deemed to perform well 
when using the PAT-VAS-OWN instead of the GP-TTO-VAL value set. The choice of value set 
therefore appears to be more important for patients seeking to avoid poorly performing hospitals. 
Moreover, we find that the GP-TTO-VAL tariff overvalues the relative performance of hospitals that 
deliver improvements in pain/discomfort and mobility compared to the PAT-VAS-OWN tariff whilst 
undervaluing those that perform relatively well at addressing anxiety/depression problems. 
Importantly, these differences appear to be driven almost entirely by the difference in the health 
state valuation technique employed (TTO vs VAS) rather than the source of valuations. Therefore, 
our results provide little empirical support for a change in reporting practice in the English PROMs 
programme because of normative concerns about the source of valuations.
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In recent years, there has been considerable interest in the use of values that reflect individuals own 
health, rather than their estimated valuations of stylised health states, to derive value sets.[22, 45] 
The purported rationale for using experience-based values is that they avoid some of the focusing 
effects that can occur in the valuation of stylised health states.[20] Furthermore, any need to reflect 
the preferences of the tax-paying general population, which mainly arises in the context of economic 
evaluation of new health technologies for use in publicly-funded health systems, can be addressed by 
using a population survey.[22] One concern with this approach is that the data collected for the 
purposes of developing an experience-based value set may only contain a limited range of responses 
to the health state descriptive system. Our study provides further evidence to demonstrate the 
feasibility of developing an experience-based value set from large-scale, routinely collected PROM 
surveys. Patients in the hip replacement sample report their HRQoL according to 148 of the 243 
possible EQ-5D-3L health states; covering a broad range of the instruments spectrum. By design, 
these are also the most commonly encountered health states in this population, limiting the need to 
extrapolate beyond the set of valued health states in most applications.  
While not the focus of our study, our findings also provide additional context to the debate about 
the comparability of EQ-5D-3L value sets developed in different countries. A study by Nemes and 
colleagues developed an experience-based VAS value set for the EQ-5D-3L using data from patients 
undergoing elective total hip replacement in Sweden.[46] The valuations of health dimensions in the 
Swedish study and those in our study are similar in that the most important dimension  both in 
terms of the decrements associated with the level 2 and 3 responses  is anxiety/depression (see 
Appendix Table 2 for estimates). Aside from this similarity, the relative importance of the various 
health dimensions differ systematically for the two value sets. This casts doubt on the ability to pool 
experienced-based value sets across countries as recently suggested for TTO value sets based on 
valuations of health states derived from valuation studies.[47]
There are a number of limitations to our analysis and proposed approach. First, a single patient 
group value set still requires aggregating valuations over a large number of patients with potentially 
heterogeneous preferences. While it is reasonable to assume that the mismatch between the 
average patient value set and individual patients preferences is smaller than the mismatch with 
average general population preferences, there may be scope for further refinement. Some existing 
work has explored how health state valuations vary with observable characteristics of the 
respondent and this line of inquiry ought to be expanded.[48] Secondly, the relationship between 
direct valuations of health states as reflected in EQ VAS scores and patients EQ-5D-3L health profiles 
has been found to change from before to after surgery.[33] The reason for this discrepancy remains 
unclear. We have chosen to estimate patient valuations from their pre-operative data since this 
reflects their ex-ante valuations at the time of their decisions. However, one may also argue that 
post-operative valuations are appropriate as they reflect patients preferences over different 
outcomes once they have started to experience the benefits of treatment. This distinction is not the 
focus of this paper, although we note that it appears to have little effect on hospital performance 
estimates, which are highly correlated under both value sets (rho>0.99) (see Appendix Table 3 for 
post-operative PAT-VAS value set and the online appendix for hospital performance scatter plots). 
Thirdly, while we find that the source of valuation is not a major driver of hospital performance 
estimates when valuing health states using VAS, we cannot generalise this statement to other 
valuation techniques such as the TTO valuations currently used in the NHS. To test this we would 
require TTO data from a sample of hip replacement patients, which we do not currently have access 
to. Fourthly, the generalizability of the findings in our study is limited to the medical condition and 
the decision problem under consideration. Finally, the limited amount of provider variation in both 
intake and health gain following THR surgery may limit the role that valuations play in determining 
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hospital performance estimates.[49] As routine PROM collection becomes more prevalent, this 
hypothesis will become testable.
In conclusion, the choice of value set to aggregate EQ-5D-3L health profiles in the context of the 
English PROMs programme may have real implications for patients choosing hospitals for their THR 
surgery. This is particularly relevant when choices are based on simple heuristics, e.g. selection 
based on dichotomized performance status rather than index scores. However, this divergence does 
not appear to be driven by the source of health state valuations, a normative concern, but rather by 
the valuation technique employed, a technical matter.
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Appendix
Appendix Table 1: Comparison of included and excluded patients in PROMs sample
 Hip replacement patient sample
 Excluded  Included
Patient age (mean, sd) 67.96 12.10 68.26 10.32
Patient gender (n, %)
Female 90,887 61% 72,095 59%
Male 58,335 39% 50,826 41%
Financial year of treatment (n, %) *
2012/13 35,259 24% 28,270 23%
2013/14 35,275 24% 33,148 27%
2014/15 39,064 26% 31,591 26%
2015/16 39,624 27%  29,912 24%
* Financial years run from April to March.
Appendix Table 2: Experienced-based VAS value sets for total hip replacement patients in England and 
Sweden
 England Sweden
Est SE Est SE
Full health 1.000 0.745
Mobility, level 2 -0.056 0.003 -0.060
Mobility, level 3 -0.119 0.012 -0.098
Self-care, level 2 -0.055 0.002
Self-care, level 3 -0.116 0.008
Self-care, level 2 or 3 -0.038
Usual activities, level 2 -0.029 0.003 -0.053
Usual activities, level 3 -0.086 0.004 -0.110
Pain/Discomfort, level 2 -0.050 0.008 -0.025
Pain/Discomfort, level 3 -0.130 0.009 -0.124
Anxiety/Depression, level 2 -0.088 0.002 -0.078
Anxiety/Depression, level 3 -0.181 0.004 -0.161
N3 0.011 0.003
Any deviation from full health -0.182 0.008    
Notes: Swedish values are taken from Nemes et al. (2015). Signs on coefficient estimates for 
England have been reversed to be compatible with Swedish values. 
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Appendix Table 3: PAT-VAS-OWN value sets calculated from PROMs data collected before or six months 
after surgery
 Before surgery  After surgery
EQ-5D dimension Est SE Est SE
Mobility, level 2 0.056 0.003 0.075 0.001
Mobility, level 3 0.119 0.012 0.177 0.024
Self-care, level 2 0.055 0.002 0.059 0.002
Self-care, level 3 0.116 0.008 0.086 0.009
Usual activities, level 2 0.029 0.003 0.050 0.001
Usual activities, level 3 0.086 0.004 0.119 0.006
Pain/Discomfort, level 2 0.050 0.008 0.032 0.001
Pain/Discomfort, level 3 0.130 0.009 0.121 0.006
Anxiety/Depression, level 2 0.088 0.002 0.083 0.001
Anxiety/Depression, level 3 0.181 0.004 0.167 0.007
N3 -0.011 0.003 0.034 0.006
Constant 0.182 0.008  0.131 0.001
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Tables and figure legends
Table 1: Overview of value set characteristics
Value Set Source of 
valuation
Valuation 
technique
Experience of 
health states
GP-TTO-VAL (Dolan 1997)
General 
population
TTO
Stylised 
description
GP-VAS-VAL
General 
population
Valuation VAS
Stylised 
description
GP-VAS-OWN
General 
population
EQ VAS Current health
PAT-VAS-OWN Patients EQ VAS Current health
Notes: TTO = Time trade-off, VAS = Visual analogue scale.
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Table 2: Descriptive statistics of PROMs and MVH samples
  
Variable
Hip replacement 
(PROMs) sample
 
General 
population (MVH) 
sample
Patient age (mean, sd) 68.26 10.32 47.86 18.37
Patient gender (n, %)
Female 72,095 58.7% 1,917 56.7%
Male 50,826 41.3% 1,464 43.3%
Symptom duration (n, %)
<1 year 16,414 13.4%
1-5 years 84,015 68.3%
6-10 years 13,967 11.4%
>10 years 7,700 6.3%
Not reported 825 0.7%
Pre-operative EQ-5D responses (mean, sd)
EQ-5D index score (GP-TTO-VAL) 0.37 0.32 0.86 0.23
EQ VAS score 65.43 21.55 82.53 16.90
Post-operative EQ-5D responses (mean, sd)
EQ-5D index score (GP-TTO-VAL) 0.80 0.24
EQ VAS score 77.34 17.61
Number of level 3 problems (pre- or post-
operatively) (n, %)
none 66,170 53.8% 3,172 93.8%
1 39,068 31.8% 161 4.8%
2 14,905 12.1% 40 1.2%
3 2,405 2.0% 8 0.2%
4 314 0.3% 0 0.0%
5 59 0.0%  0 0.0%
Sample size 122,921 3,381
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Table 3: Estimated EQ-5D health dimension decrements and standard errors
 GP-TTO-VAL  GP-VAS-VAL  GP-VAS-OWN  PAT-VAS-OWN
EQ-5D dimension Est SE Est SE Est SE Est SE
Mobility, level 2 0.069 0.005 0.071 0.004 0.059 0.010 0.047 0.002
Mobility, level 3 0.314 0.007 0.182 0.005 0.152 0.084 0.117 0.011
Self-care, level 2 0.104 0.005 0.093 0.004 0.067 0.018 0.057 0.001
Self-care, level 3 0.214 0.007 0.145 0.005 0.080 0.097 0.104 0.007
Usual activities, level 2 0.036 0.006 0.031 0.004 0.082 0.011 0.042 0.002
Usual activities, level 3 0.094 0.007 0.081 0.005 0.139 0.034 0.097 0.003
Pain/Discomfort, level 2 0.012 0.005 0.084 0.004 0.065 0.006 0.047 0.006
Pain/Discomfort, level 3 0.386 0.006 0.171 0.004 0.100 0.034 0.119 0.007
Anxiety/Depression, level 2 0.071 0.071 0.063 0.004 0.072 0.007 0.085 0.001
Anxiety/Depression, level 3 0.236 0.006 0.124 0.004 0.151 0.034 0.173 0.003
N3 0.269 0.007 0.215 0.005 0.064 0.036 -0.020 0.003
Constant 0.081 0.008  0.159 0.004  0.104 0.002  0.121 0.005
Source of valuation General population  General population  General population  Patients
Valuation technique TTO Valuation VAS EQ VAS EQ VAS
Experience of health states Stylised description  Stylised description  Current health  Current health
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Table 4: Index scores at patient level (mean, SD) and range of scores at provider level under four value sets
Value set Pre-operative  
Post-operative
(unadjusted)
 
Post-operative
(case-mix adjusted)
 Mean SD
Range of hospital 
mean scores
 Mean SD
Range of hospital 
mean scores
 Mean SD
Range of hospital 
mean scores
GP-TTO-VAL 0.364 0.320 0.243 to 0.576 0.802 0.239 0.568 to 1 0.804 0.216 0.632 to 1
GP-VAS-VAL 0.441 0.202 0.227 to 0.571 0.789 0.216 0.599 to 1 0.791 0.195 0.593 to 0.998
GP-VAS-OWN 0.579 0.116 0.449 to 0.673 0.826 0.173 0.687 to 1 0.828 0.155 0.629 to 0.987
PAT-VAS-OWN 0.625 0.101 0.496 to 0.711  0.832 0.162 0.708 to 1  0.834 0.144 0.646 to 0.975
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Figure 1: Selected health state valuations under different value sets
Figure 2: Relationship between hospital performance estimates under different value sets
Figure 3: Number of statistically significant good/bad performers within patients' five closest hospitals under different value 
sets
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Abstract
Background: The English NHS publishes hospital performance indicators based on average post-
operative EQ-5D index scores after hip replacement surgery to inform prospective patients choices 
of hospital. Unidimensional index scores are derived from multidimensional health-related quality of 
life data using preference weights estimated from a sample of the UK general population. This raises 
normative concerns if general population preferences differ from those of the patients that are to be 
informed. This study explores how the source of valuation affects hospital performance estimates.
Methods: Four different value sets reflecting source of valuation (general population vs. patients), 
valuation technique (visual analogue scale (VAS) vs. time trade-off (TTO)) and experience with health 
states (currently experienced vs experimentally estimated) were used to derive and compare 
performance estimates for 243 hospitals. Two value sets were newly estimated from EQ-5D-3L data 
on 122,921 hip replacement patients and 3,381 members of the UK general public. Changes in 
hospital ranking (nationally; amongst patients five closest hospitals) and performance outlier status 
(nationally; amongst patients five closest hospitals) were compared across valuations. 
Results: National rankings are stable under different valuations (Spearman rank correlations > 
0.9392) but differ substantially at the local level. Twenty-three (9.5%) hospitals change outlier status 
when using patient VAS valuations instead of general population TTO valuations, the current 
approach. Outlier status also changes substantially at local level. This is explained nearly 
entirelymostly by the valuation technique, not the source of valuations or experience with the 
health states. 
Limitations: No patient TTO valuations were available. Effect of value set characteristics could only 
be established through indirect comparisons.
Conclusion: Different value sets may lead to prospective patients choosing different hospitals. 
Normative concerns about the use of general population valuations are not supported by empirical 
evidence based on VAS valuations.  
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1 Introduction
Patients in the English National Health Service (NHS) have the right to choose among all qualified 
hospital providers for treatments that are deemed clinically appropriate and are publicly funded. To 
inform patients [] exercising choice (p.6)[1] about the quality of care they are likely to receive, 
the English NHS routinely collects multidimensional health-related quality of life (HRQoL) data from 
patients before and after undergoing planned hip and knee replacement surgical as part of the 
national patient-reported outcome measures (PROMs) programme. These data are then used to 
benchmark hospitals and calculate performance indicators in the form of case-mix adjusted average 
post-operative HRQoL, expressed as unidimensional composite scores, which are made publicly 
available on a regular basis.[2, 3] 
A normative question, and the focus of this paper, is how to aggregate the multidimensional HRQoL 
data into unidimensional (single number) scores for the purpose of hospital performance 
assessment and public reporting. The PROMs programme collects HRQoL data using a generic health 
measurement instrument, the EQ-5D-3L[4], which comprises both a direct and indirect measure of a 
patients health state. The direct measure, the EQ VAS, asks patients to provide a summary 
assessment of their HRQoL by marking a position on a visual analogue scale (VAS) ranging from 0 to 
100, where the endpoints reflect the best and worst health states imaginable. The indirect measure 
uses the EQ-5D-3L descriptive system, where patients are asked to describe their current health 
status according to five dimensions of health (mobility, self-care, usual activities, pain & discomfort 
and anxiety & depression), each of which can be assigned one of three severity levels (essentially no, 
some or extreme problems). The resulting health profile data are aggregated into unidimensional 
composite (index) scores using preference estimates of the UK general population[5], rather than 
of those prospective patients the PROMs programme seeks to inform. Previous research has shown 
many cases where preference estimates derived from specific patient populations differ 
systematically from those derived from the general population[6-10] although some studies find no 
differences [11, 12]. The current practice therefore raises normative concerns and could be 
inconsistent with the notion of patient sovereignty if it leads to a mismatch between the decisions 
patients make based on official published data, and those they would have made had the 
information reflected their own preferences more closely. 
Ideally, the reported hospital performance should reflect prospective patients individual 
preferences over relevant health states. However, the elicitation of personal preference functions is 
a complex and time-consuming task[13] and has therefore not (yet) found widespread adoption in 
the public reporting of hospital performance. Furthermore, it would imply the need to re-calculate 
public reports for each prospective patient based on their individual preferences, ruling out static 
performance reports (e.g. rankings published in newspapers) that are common currently. A 
pragmatic solution, that avoids both issues, is to develop a value set based on preferences elicited 
from a sample of patients. Such value sets are likely to reflect the preferences of prospective 
patients more closely than a general population value set since they are obtained from a sample of 
individuals with a similar age-sex structure, clinical condition, adaptation to their condition, and 
expectations of future health. At the same time, it would enable the calculation of EQ-5D index 
scores and, hence, unidimensional hospital performance indicators that could be presented 
alongside detailed dimension-by-dimension estimates[14] if desired. 
In this paper we test whether the use of patient or general population valuations generates different 
hospital performance estimates for hip replacement surgery in the English NHS. We are not aware of 
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a UK-based patient value set that mirrors the currently used general population value set in terms of 
two other important aspects, namely respondents experience of the health state to be valued as 
well as the valuation technique employed. This precludes a direct test of the effect of the source of 
valuation on hospital performance estimates. Instead, we compare hospital performance estimates 
generated under a numberfour of published and newly-estimated value sets, out of eight possible 
combinations of these value set attributes. This allows us to vary one aspect at a time, holding the 
other two constant. The results of this indirect comparison help to demonstrate the practical 
implications of the normative argument about the source of health state valuations in the context of 
informing prospective patients about where to have surgery.
2 Valuation of health states
Amongst the desirable properties of a measure of the value of health is that it should unambiguously 
indicate whether a given health state, as defined by a multidimensional HRQoL profile, is better 
than, worse than, or equivalent to another health state. This property is most usually achieved by 
aggregating HRQoL data into a single number that represents the value of a health state by means of 
a set of preference weights. By convention, the value of a health state lies on a scale where 1 
represents health which as good as possible, and 0 represents health that is either as poor as 
possible or is equivalent to being dead. The latter allows for health states worse than dead with 
values below 0.
Any attempt to value health in this way requires consideration of the following questions: (1) what is 
being valued; (2) whose values are being sought; and (3) what technique is being used to obtain the 
values? These are each briefly summarised below with interested readers being referred to detailed 
discussions elsewhere.[15-17]
2.1 What is being valued
Health state valuations are obtained as part of elicitation tasks.  In these, participants may be asked 
to value their own health, as experienced either currently or in the past, or a set of health states that 
they may not be currently experiencing. For the latter, they are usually asked to value a stylised 
description of health, which may take the form of a health state profile comprising a series of 
dimensions and severity levels defined by the descriptive system of a PROM instrument, such as the 
EQ-5D. Such profiles are often described as hypothetical, but this is misleading because they are 
intended to reflect real health states and therefore plausible ways in which someone might self-
report their health using the instrument. Since in most cases respondents will neither be 
experiencing or ever have experienced a health state described in the profile, they would need to 
imagine living in that health state in order to evaluate it. We can therefore regard these as their 
estimate of how they would value the health state if they were experiencing it.
2.2 Whose values are being sought
Health state valuations can be obtained from selected subgroups, such as patients with a given 
medical condition, or a sample of the general population.[16, 18, 19] Both approaches have merit, 
although advocates tend to argue their case on different grounds. Those in favour of using patient 
valuations typically point out that patients have N	 experience of health states and therefore 
do not need to imagine the impact of an unfamiliar health state on their HRQoL.[20, 21] A common 
finding in the published literature - that valuations derived from specific patient populations tend to 
be higher than those elicited from the general population - has been attributed to patients adapting 
to their impaired health state over time and/or providing a more accurate assessment of the health 
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state based on their lived experience.[6, 7, 21] Conversely, proponents of general population 
valuations typically argue their case not on the grounds of validity but based on the intended use of 
such valuations to inform resource allocation decision in collectively funded health services, where 
decisions should reflect the preferences of the general population paying into the system.[18]
It is important to note that what is being valued and by whom are two separate issues. Patients may 
be asked to value health states that can occur as a result of their medical condition and which they 
may be able to imagine living in, but which they have not (yet) experienced themselves. Equally, the 
general population can be asked to value their currently experienced health state.[22]
2.3 What elicitation technique is being used
There are a number of techniques for valuing health states such as VAS and time trade-off (TTO).[23] 
The VAS involves rating the health state on a scale with imposed interval properties and well-defined 
endpoints, conventionally 0 and 100 (which in the EQ VAS represent worst and best imaginable 
health, respectively). TTO involves making a series of choices between living for a fixed amount of 
time in the profile under evaluation and a shorter, variable amount of time in full health, where the 
point at which respondents are indifferent is used to infer valuations. TTO has become the method 
most often recommended for the generation of values. The two methods have different 
assumptions underpinning them and are subject to different types of framing effects, for example 
VAS valuations are known to be subject to end-of-scale aversion [24] whereas respondents time 
preference can have an effect on TTO valuations [25, 26]. VAS exercises are widely considered to be 
relatively simple and feasible to complete.[27] Previous research has shown that VAS and TTO yield 
different results.[28]
3 Methods
3.1 Data 
We analyse EQ-5D-3L data from two independent samples. The first consists of 272,445 NHS-funded 
total hip replacement (THR) patients aged 15 years or over who had primary surgery in public or 
private hospitals in England between April 2012 and March 2016, collected as part of the English 
national PROMs programme[1]. Patients completed a paper questionnaire shortly before and six 
months after having surgery, containing the EQ-5D-3L, a condition-specific measure (the Oxford Hip 
Score) and other questions about their condition and treatment. The pre-operative questionnaire 
was administered by hospital staff at admission or the last outpatient appointment preceding 
admission and forwarded to a central data processor. The post-operative questionnaire was mailed 
directly to the patients home address. Returned questionnaires were linked to administrative 
hospital records from the Hospital Episode Statistics (HES) database through a probabilistic matching 
algorithm. HES provides information on patients age, place of residence, provider of care, and 
whether the surgery was a revision of a previous THR. Further details about the PROM data 
collection procedure are provided elsewhere.[29, 30] We excluded patients for whom pre- or post-
operative responses were missing, either in part or completely, or where questionnaires could not 
be linked to HES. The sample used to estimate the patient value set in this study included 122,921 
patients, which corresponds to 45.1% of all THR patients that were eligible to participate in the 
PROMs survey. Excluded patients were on average slightly younger and more likely to be female 
(Appendix Table 1). The linked HES-PROMs dataset was provided by NHS Digital.
The second sample consists of 3,381 randomly selected members of the UK general public that took 
part in the Measurement and Valuation of Health (MVH) study.[31] Each of the participants were 
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6
asked as part of face-to-face interviews to rate their own health status using the EQ-5D-3L 
questionnaire and to value 8 of 42 stylised health states using TTO[32] and VAS. The valuation data 
were used to derive a TTO based value set known as the MVH-A1 [5], but which we label the GP-
TTO-VAL, and a VAS based value set known as the MVH-A3, but which we label the GP-VAS-VAL 
(Table 1).[31] The former is used in the official calculation of the hospital performance estimates 
reported to the public. Both value sets are anchored at 1 (full health) and 0 (dead), with scores 
below 0 indicating states considered worse than being dead. The MVH dataset was provided by the 
UK Data Services.
3.2 Estimation of experience-based value sets
A patient, current health VAS value set, which we label the PAT-VAS-OWN, was derived from the 
national PROMs dataset by regressing patient-reported EQ VAS scores on variables representing the 
levels within each dimension of the EQ-5D descriptive system, using Ordinary Least Squares. The 
regression model underpinning the MHV value sets include dummy variables for the main effects, a 
constant term reflecting any deviation from full health, and an N3 term indicating extreme problems 
(level 3) on any dimension.[5] To ensure comparability with these, we used the same specification. 
We also estimated more saturated models allowing for pairwise interactions between dimensions at 
level 2 and 3, but found these added little to overall fit (results available on request). 
The PAT-VAS-OWN value set was estimated on data for the period April 2012 to March 2015, leaving 
one year of data to assess the impact of the value set on hospital rankings (see Section 2.4). It has 
been observed that patients valuations of the same description of their health state may change from 
pre- to post-surgery, which may lead to inconsistencies when estimating patient-based value sets.[33] 
We focus our analysis on pre-operative survey responses since these are more likely to reflect 
patients preferences at the point in time when a choice is to be made.
We also estimated a general population, current health VAS value set, which we label the GP-VAS-
OWN, using the MVH study participants EQ VAS and self-classifier responses and the same 
modelling structure as for the PAT-VAS-OWN value set. 
Table 1 summarises the characteristics of the four value sets that we compared.
All standard errors are robust to heteroscedasticity and, in the case of the PAT-VAS-OWN value set, 
are clustered at hospital level. All computations were performed in Stata 14 (StataCorp LP, College 
Station, TX).
3.3 Deriving hospital performance estimates
Hospital performance assessment aims to identify the systematic contribution that providers make 
to their patients health outcomes.[34] To allow for fair comparisons these assessments need to 
adjust for differences in hospital case-mix and sampling uncertainty.
Our analysis followed the published adjustment methodology of NHS England[35], in which the case-
mix adjusted performance  of hospital  is estimated as = 	
= 1
 
= 1( )
where  is the observed post-operative index score for patient  and  is the expected  = 1,,
 
post-operative index score for the same patient given their observable characteristics. The case-mix 
adjusted performance estimates  are themselves expressed as index scores.
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The expected post-operative index score is based on the official case-mix adjustment methodology 
developed by NHS England[35]. The adjustment takes account of age, gender, ethnicity, living 
arrangements, the income deprivation profile of the patients local small areas of residence (Lower-
Layer Super Output Area (LSOA)) as approximated by the 2010 Index of Deprivation[36], main 
diagnosis and comorbid conditions, whether patients lived alone, whether they required assistance 
when filling in the PROMs questionnaire or considered themselves to be disabled, the duration of 
symptoms, as well as their pre-operative EQ-5D index score. We estimate the case-mix adjustment 
model separately for each of the four value sets using data from April 2012 to March 2014.
To account for sampling uncertainty in performance scores we follow standard practice[37-39] in the 
NHS and calculated z-score statistics for each hospital as= ( ))
where  indicates statistically significant divergent performance from the national average > 1.96
at the 5% level. Hospitals with  were deemed to perform well if  and poorly > 1.96 > 0
otherwise. Performance estimates that were not statistically significantly different from the national 
average were deemed average. This approach is consistent with the simplified pictorial display used 
to communicate performance information (green, blue and red buttons to denote good, average 
and poor performance) by NHS choices[2] and other hospital comparison websites[3].
3.4 Assessing the impact of different EQ-5D value sets on hospital 
performance estimates
We assessed the impact of different value sets on hospital performance estimates for the period 
between April 2015 and March 2016 through a series of head-to-head comparisons. For each hospital, 
we compared their performance status (i.e. whether they were judged to perform well, poorly, or 
average) under different value sets and quantified discrepancies. The strength of association between 
hospital performance estimates rankings generated with different value sets is was measured using 
Pearsons Spearmans rank correlation coefficient . 
One motivation for considering patient valuations in assessing hospital performance is the desire to 
provide prospective patients with information that will inform their choice of hospital. Yet, most 
patients are unwilling to travel far for healthcare treatment[40-42], with a recent study[43] 
suggesting that over 92% of THR patients in the English NHS chose to attend one of their five closest 
hospitals in the period 2010 to 2012. We therefore also explored the impact of value sets at the local 
level; for each patient, we assessed how many of their five closest hospitals would be flagged as 
performing well or poorly under the different value setsexamined whether the performance ranking 
for the five closest hospitals changed when different value sets were used to derive health state 
values. This choice set was determined by the straight-line distance between the centroid of the 
patients LSOA of residence and the hospitals postcodes.[43] Additionally, we assessed how many of 
these hospitals would be flagged as performing well or poorly under the different value sets. This 
approach is consistent with the simplified pictorial display used to communicate performance 
information (green, blue and red buttons to denote good, average and poor performance) by NHS 
choices[2] and other hospital comparison websites[3].
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4 Results
4.1 Descriptive statistics
Table 2 reports descriptive statistics of the data samples. Patients in the national PROMs programme 
sample were, on average, 68 years old and 58.7% were female. Most patients had suffered from 
joint-related symptoms for 1 to 5 years prior to surgery. The average improvement in HRQoL six 
months after surgery was equivalent to an increase of 0.43 value points (from 0.37 to 0.80) (MVH-A1 
value set), and patients overall assessment of their health as measured by the EQ VAS increased by 
12 points (from 65 to 77). Patients described their pre-operative HRQoL using 148 of the 243 
possible EQ-5D-3L health states. The relative frequency of these health states was consistent with 
the severity of the conditions that require major joint replacement. Over 46% of patients reported 
extreme limitation (i.e. level 3 problems) on at least one HRQoL dimension before surgery, and >2% 
reported extreme limitations on three or more dimensions.
Unsurprisingly, MVH study participants reported better health on average than the patient sample, 
both pre- and post-surgery.  They were, on average, significantly younger (mean age = 47.9 years) 
than the patient population but showed a similar sex split (56.7% female). Participants described 
their health using 77 of the 243 EQ-5D-3L health states, with 4.8% of participants having at least one 
extreme limitation on any of the five health dimensions. The average VAS score was 82.5 and the 
average EQ-5D value based on the GP-TTO-VAL value set was 0.86.
4.2 Value sets 
Table 3 reports the estimated PAT-VAS-OWN and GP-VAS-OWN value sets alongside the published 
GP-TTO-VAL and GP-VAS-VAL value sets. Coefficient estimates represent decrements associated with 
some or extreme limitations on a given health dimension. The constant and the N3 term reflect 
global decrements that are applied in the presence of any limitations on any health dimension and 
at least one extreme limitation on any health dimension, respectively. 
Figure 1 shows the values generated by the different value sets for the 42 stylised health states 
valued in the MVH study.
Both PAT-VAS-OWN and GP-VAS-OWN value sets were found to be internally consistent, i.e. more 
severe limitations are associated with larger decrements for each dimension. Patients assign 
approximately equal or smaller decrements to health problems on a given dimension than the 
general public, but they attach a larger global decrement to the presence of any health problems as 
reflected in the coefficient on the constant term. Differences are more pronounced on level 3 
decrements than level 2 decrements, thus generating a wider spread of index scores across the four 
value sets for health states for which respondents reported at least one extreme problem. These 
results are consistent with previous evidence from other patient populations.[7, 44] It should be 
noted that because of the smaller sample size, the GP-VAS-OWN data has sparse observations in 
some of the levels within dimensions, particularly Mobility Level 3, which means that the coefficient 
estimates have very large standard errors.
Table 4 reports descriptive statistics of the pre- and post-operative index scores reported at patient 
level (mean, SD) as well as the range of hospital average scores calculated using the four value sets. 
Differences in average index scores are more pronounced prior to surgery than afterwards, which 
reflects the low number of patients reporting any extreme problems after surgery. The two value 
sets based on direct valuations of own, currently experienced health (GP-VAS-OWN, PAT-VAS-OWN) 
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generate, on average, higher index scores as well as a smaller spread of hospital average index 
scores that are relevant for performance assessment. Histograms of case-mix adjusted hospital 
scores are presented in the online appendix.
4.3 Impact on judgements about hospital performance
Figure 2 presents scatter plots of hospital z-scores derived under different EQ-5D value sets. Each 
scatter point represents one hospital, with dashed lines indicating the lower and upper boundaries 
at which performance estimates are deemed to be statistically significantly different from the 
national average. Performance estimates that would lead to differential judgement under the two 
value sets being compared are highlighted as diamonds (significant under the first but not the 
second value set) or squares (vice versa). 
The GP-TTO-VAL and PAT-VAS-OWN value sets generate performance estimates that are highly 
correlated (  = 0.9392) (Figure 2, Panel A). Despite this, the change in value set has a non-negligible 
impact on how individual hospitals are deemed to perform, with patient valuations leading to 
changes in outlier status for 23 hospitals in total (9.5% of 243), of which 6 (2.5%) are no longer 
identified as performing poorly, 10 (4.1%) are no longer identified as performing well, and seven 
different hospitals now appear to perform well (2.9%). At the local level, 1% fewer patients (44% vs 
45% of N=65,278) receiving care between April 2015 and March 2016 would have found at least one 
well performing hospital within their five closest hospitals if performance estimates had been 
derived using the PAT-VAS-OWN value set rather than the GP-TTO-VAL (Figure 3). In contrast, 
patients would have been 10% more likely (34% vs 24%) to find at least one local hospital deemed to 
perform poorly if performance estimates had been derived using the PAT-VAS-OWN value set. 
Overall, at least one performance assessment for their five closest hospitals would have been 
different for 8.6% of patients receiving care between April 2015 and March 2016. 
To further explore the reasons for this divergence, we compared hospital performance estimates 
derived varying one value set design characteristic (i.e. source of valuation, valuation technique, or 
experience with health state) while holding the others constant (Figure 2, Panels B-D). The results of 
this marginal analysis suggest that neither the source of valuation nor the level of experience with a 
health state drive the observed differences in hospital performance classifications. Instead, these 
differences can be explained nearly entirely by the choice of valuation technique employed, with 
Panel B showing many more changes in outlier status than Panel C and D.
5 Discussion
There is a strong normative rationale for using patient values to aggregate multidimensional HRQoL 
instruments when developing hospital performance indicators to inform prospective patients 
choices of hospital. However, the standard practice in the English NHS has been to publish hospital 
performance indicators based on EQ-5D scores aggregated using general public values. The present 
study explores whether this practice may be distorting patients' choice of hospital for hip 
replacement surgery given that there is some evidence of discrepancies between patient and 
general public values. We find a larger number of hospitals are deemed to perform poorly when a 
patient VAS tariff (PAT-VAS-OWN) is used compared to when the UK general population TTO tariff 
(GP-TTO-VAL) is used. Conversely, we find only slightly fewer hospitals are deemed to perform well 
when using the PAT-VAS-OWN instead of the GP-TTO-VAL value set. The choice of value set 
therefore appears to be more important for patients seeking to avoid poorly performing hospitals. 
Moreover, we find that the GP-TTO-VAL tariff overvalues the relative performance of hospitals that 
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deliver improvements in pain/discomfort and mobility compared to the PAT-VAS-OWN tariff whilst 
undervaluing those that perform relatively well at addressing anxiety/depression problems. 
Importantly, these differences appear to be driven almost entirely by the difference in the health 
state valuation technique employed (TTO vs VAS) rather than the source of valuations. Therefore, 
our results provide little empirical support for a change in reporting practice in the English PROMs 
programme because of normative concerns about the source of valuations.
In recent years, there has been considerable interest in the use of values that reflect individuals own 
health, rather than their estimated valuations of stylised health states, to derive value sets.[22, 45] 
The purported rationale for using experience-based values is that they avoid some of the focusing 
effects that can occur in the valuation of stylised health states.[20] Furthermore, any need to reflect 
the preferences of the tax-paying general population, which mainly arises in the context of economic 
evaluation of new health technologies for use in publicly-funded health systems, can be addressed by 
using a population survey.[22] One concern with this approach is that the data collected for the 
purposes of developing an experience-based value set may only contain a limited range of responses 
to the health state descriptive system. Our study provides further evidence to demonstrate the 
feasibility of developing an experience-based value set from large-scale, routinely collected PROM 
surveys. Patients in the hip replacement sample report their HRQoL according to 148 of the 243 
possible EQ-5D-3L health states; covering a broad range of the instruments spectrum. By design, 
these are also the most commonly encountered health states in this population, limiting the need to 
extrapolate beyond the set of valued health states in most applications.  
While not the focus of our study, our findings also provide additional context to the debate about 
the comparability of EQ-5D-3L value sets developed in different countries. A study by Nemes and 
colleagues developed an experience-based VAS value set for the EQ-5D-3L using data from patients 
undergoing elective total hip replacement in Sweden.[46] The valuations of health dimensions in the 
Swedish study and those in our study are similar in that the most important dimension  both in 
terms of the decrements associated with the level 2 and 3 responses  is anxiety/depression (see 
Appendix Table 2 for estimates). Aside from this similarity, the relative importance of the various 
health dimensions differ systematically for the two value sets. This casts doubt on the ability to pool 
experienced-based value sets across countries as recently suggested for TTO value sets based on 
valuations of health states derived from valuation studies.[47]
There are a number of limitations to our analysis and proposed approach. First, a single patient 
group value set still requires aggregating valuations over a large number of patients with potentially 
heterogeneous preferences. While it is reasonable to assume that the mismatch between the 
average patient value set and individual patients preferences is smaller than the mismatch with 
average general population preferences, there may be scope for further refinement. Some existing 
work has explored how health state valuations vary with observable characteristics of the 
respondent and this line of inquiry ought to be expanded.[48] Secondly, the relationship between 
direct valuations of health states as reflected in EQ VAS scores and patients EQ-5D-3L health profiles 
has been found to change from before to after surgery.[33] The reason for this discrepancy remains 
unclear. We have chosen to estimate patient valuations from their pre-operative data since this 
reflects their ex-ante valuations at the time of their decisions. However, one may also argue that 
post-operative valuations are appropriate as they reflect patients preferences over different 
outcomes once they have started to experience the benefits of treatment. This distinction is not the 
focus of this paper, although we note that it appears to have little effect on hospital performance 
estimates, which are highly correlated under both value sets (rho>0.99) (see Appendix Table 3 for 
post-operative PAT-VAS value set and the online appendix for hospital performance scatter plots). 
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Thirdly, while we find that the source of valuation is not a major driver of hospital performance 
estimates when valuing health states using VAS, we cannot generalise this statement to other 
valuation techniques such as the TTO valuations currently used in the NHS. To test this we would 
require TTO data from a sample of hip replacement patients, which we do not currently have access 
to. Fourthly, the generalizability of the findings in our study is limited to the medical condition and 
the decision problem under consideration. Finally, the limited amount of provider variation in both 
intake and health gain following THR surgery may limit the role that valuations play in determining 
hospital performance estimates.[49] As routine PROM collection becomes more prevalent, this 
hypothesis will become testable.
In conclusion, the choice of value set to aggregate EQ-5D-3L health profiles in the context of the 
English PROMs programme may have real implications for patients choosing hospitals for their THR 
surgery. This is particularly relevant when choices are based on simple heuristics, e.g. selection 
based on dichotomized performance status rather than index scores. However, this divergence does 
not appear to be driven by the source of health state valuations, a normative concern, but rather by 
the valuation technique employed, a technical matter.
Page 37 of 49
http://mc.manuscriptcentral.com/mdm
Medical Decision Making
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
12
Appendix
Appendix Table 1: Comparison of included and excluded patients in PROMs sample
 Hip replacement patient sample
 Excluded  Included
Patient age (mean, sd) 67.96 12.10 68.26 10.32
Patient gender (n, %)
Female 90,887 61% 72,095 59%
Male 58,335 39% 50,826 41%
Financial year of treatment (n, %) *
2012/13 35,259 24% 28,270 23%
2013/14 35,275 24% 33,148 27%
2014/15 39,064 26% 31,591 26%
2015/16 39,624 27%  29,912 24%
* Financial years run from April to March.
Appendix Table 2: Experienced-based VAS value sets for total hip replacement patients in England and 
Sweden
 England Sweden
Est SE Est SE
Full health 1.000 0.745
Mobility, level 2 -0.056 0.003 -0.060
Mobility, level 3 -0.119 0.012 -0.098
Self-care, level 2 -0.055 0.002
Self-care, level 3 -0.116 0.008
Self-care, level 2 or 3 -0.038
Usual activities, level 2 -0.029 0.003 -0.053
Usual activities, level 3 -0.086 0.004 -0.110
Pain/Discomfort, level 2 -0.050 0.008 -0.025
Pain/Discomfort, level 3 -0.130 0.009 -0.124
Anxiety/Depression, level 2 -0.088 0.002 -0.078
Anxiety/Depression, level 3 -0.181 0.004 -0.161
N3 0.011 0.003
Any deviation from full health -0.182 0.008    
Notes: Swedish values are taken from Nemes et al. (2015). Signs on coefficient estimates for 
England have been reversed to be compatible with Swedish values. 
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Appendix Table 3: PAT-VAS-OWN value sets calculated from PROMs data collected before or six months 
after surgery
 Before surgery  After surgery
EQ-5D dimension Est SE Est SE
Mobility, level 2 0.056 0.003 0.075 0.001
Mobility, level 3 0.119 0.012 0.177 0.024
Self-care, level 2 0.055 0.002 0.059 0.002
Self-care, level 3 0.116 0.008 0.086 0.009
Usual activities, level 2 0.029 0.003 0.050 0.001
Usual activities, level 3 0.086 0.004 0.119 0.006
Pain/Discomfort, level 2 0.050 0.008 0.032 0.001
Pain/Discomfort, level 3 0.130 0.009 0.121 0.006
Anxiety/Depression, level 2 0.088 0.002 0.083 0.001
Anxiety/Depression, level 3 0.181 0.004 0.167 0.007
N3 -0.011 0.003 0.034 0.006
Constant 0.182 0.008  0.131 0.001
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Tables and figure legends
Table 1: Overview of value set characteristics
Value Set Source of 
valuation
Valuation 
technique
Experience of 
health states
GP-TTO-VAL (Dolan 1997)
General 
population
TTO
Stylised 
description
GP-VAS-VAL
General 
population
Valuation VAS
Stylised 
description
GP-VAS-OWN
General 
population
EQ VAS Current health
PAT-VAS-OWN Patients EQ VAS Current health
Notes: TTO = Time trade-off, VAS = Visual analogue scale.
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Table 2: Descriptive statistics of PROMs and MVH samples
  
Variable
Hip replacement 
(PROMs) sample
 
General 
population (MVH) 
sample
Patient age (mean, sd) 68.26 10.32 47.86 18.37
Patient gender (n, %)
Female 72,095 58.7% 1,917 56.7%
Male 50,826 41.3% 1,464 43.3%
Symptom duration (n, %)
<1 year 16,414 13.4%
1-5 years 84,015 68.3%
6-10 years 13,967 11.4%
>10 years 7,700 6.3%
Not reported 825 0.7%
Pre-operative EQ-5D responses (mean, sd)
EQ-5D index score (GP-TTO-VAL) 0.37 0.32 0.86 0.23
EQ VAS score 65.43 21.55 82.53 16.90
Post-operative EQ-5D responses (mean, sd)
EQ-5D index score (GP-TTO-VAL) 0.80 0.24
EQ VAS score 77.34 17.61
Number of level 3 problems (pre- or post-
operatively) (n, %)
none 66,170 53.8% 3,172 93.8%
1 39,068 31.8% 161 4.8%
2 14,905 12.1% 40 1.2%
3 2,405 2.0% 8 0.2%
4 314 0.3% 0 0.0%
5 59 0.0%  0 0.0%
Sample size 122,921 3,381
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Table 3: Estimated EQ-5D health dimension decrements and standard errors
 GP-TTO-VAL  GP-VAS-VAL  GP-VAS-OWN  PAT-VAS-OWN
EQ-5D dimension Est SE Est SE Est SE Est SE
Mobility, level 2 0.069 0.005 0.071 0.004 0.059 0.010 0.047 0.002
Mobility, level 3 0.314 0.007 0.182 0.005 0.152 0.084 0.117 0.011
Self-care, level 2 0.104 0.005 0.093 0.004 0.067 0.018 0.057 0.001
Self-care, level 3 0.214 0.007 0.145 0.005 0.080 0.097 0.104 0.007
Usual activities, level 2 0.036 0.006 0.031 0.004 0.082 0.011 0.042 0.002
Usual activities, level 3 0.094 0.007 0.081 0.005 0.139 0.034 0.097 0.003
Pain/Discomfort, level 2 0.012 0.005 0.084 0.004 0.065 0.006 0.047 0.006
Pain/Discomfort, level 3 0.386 0.006 0.171 0.004 0.100 0.034 0.119 0.007
Anxiety/Depression, level 2 0.071 0.071 0.063 0.004 0.072 0.007 0.085 0.001
Anxiety/Depression, level 3 0.236 0.006 0.124 0.004 0.151 0.034 0.173 0.003
N3 0.269 0.007 0.215 0.005 0.064 0.036 -0.020 0.003
Constant 0.081 0.008  0.159 0.004  0.104 0.002  0.121 0.005
Source of valuation General population  General population  General population  Patients
Valuation technique TTO Valuation VAS EQ VAS EQ VAS
Experience of health states Stylised description  Stylised description  Current health  Current health
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Table 4: Index scores at patient level (mean, SD) and range of scores at provider level under four value sets
Value set Pre-operative  
Post-operative
(unadjusted)
 
Post-operative
(case-mix adjusted)
 Mean SD
Range of hospital 
mean scores
 Mean SD
Range of hospital 
mean scores
 Mean SD
Range of hospital 
mean scores
GP-TTO-VAL 0.364 0.320 0.243 to 0.576 0.802 0.239 0.568 to 1 0.804 0.216 0.632 to 1
GP-VAS-VAL 0.441 0.202 0.227 to 0.571 0.789 0.216 0.599 to 1 0.791 0.195 0.593 to 0.998
GP-VAS-OWN 0.579 0.116 0.449 to 0.673 0.826 0.173 0.687 to 1 0.828 0.155 0.629 to 0.987
PAT-VAS-OWN 0.625 0.101 0.496 to 0.711  0.832 0.162 0.708 to 1  0.834 0.144 0.646 to 0.975
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Figure 1: Selected health state valuations under different value sets
Figure 2: Relationship between hospital performance estimates under different value sets
Figure 3: Number of statistically significant good/bad performers within patients' five closest hospitals under different value 
sets
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MDM-19-321-R1. Using EQ-5D Data to Measure Hospital Performance: Are General Population 
Values Distorting Patients' Choices?
We thank the reviewer for the helpful set comments and suggestions. A response to each point is 
provided. The comments from the reviewer are in bold (numbered for ease of reference) with our 
responses below. 
Reviewer 1
R1) In abstract it first implies that rankings did not change overall, but changed on the local level. 
This is confusing- but in the paper itself, it seems there were no rankings on the local level, but 
rather a determination of outlier status. Abstract may need correction.
The reviewer is correct. We have amended the abstract from:
Changes in hospital ranking (nationally; amongst patients five closest hospitals) and 
performance outlier status were compared across valuations.
to
Changes in hospital ranking (nationally) and performance outlier status (nationally; amongst 
patients five closest hospitals) were compared across valuations. 
R2) I still find the last paragraph of the Introduction confusing, especially as it emphasizes what is 
not done or possible to do. Could it be written more directly- e.g. include sentences such as: In 
this paper we compute EQ-5D-3L scores for hip replacement patients in the English NHS based on 
valuations that differ in whether they were obtained from patients or the general population, 
based on stylized descriptions or own health, and based on VAS versus TTO. Out of 8 possible 
combinations of these factors, we have data on four (see Table 1), allowing comparison of general 
population and patients based on valuation of own health on VAS, comparison of own health 
versus stylized description for VAS based valuations in the general population and VAS based 
versus TTO valuations for stylized descriptions in the general population. We are not aware of a 
UK-based patient value set that mirrors the currently used general population value set to allow 
direct comparisons of VAS versus TTO valuations or own versus stylized health valuations within 
the patient group. However, available data allows us to test one aspect of valuations at a time 
while keeping the others constant.
We thank the reviewer for this suggestion. However, the suggested text does not match with the 
motivation for our paper, which is to compare the use of general population valuations to that of 
patient valuations and analyse the impact that this has on hospital performance measurement. The 
key point is that we do not have data with which to test this directly, so we use indirect 
comparisons, which are limited by the available value sets and data. The suggested text implies we 
are testing, with equal importance, the effect of valuation technique, experience with health state 
and source of valuations. Our paper does not have that broader motivation.
We have therefore not changed this paragraph substantially, but have edited the text to clarify that 
we are comparing four of out of eight possible value sets.
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R3) It is mentioned that Standard errors are robust, taking into account hospital clustering for 
patients. However, SD (Table 4) do not take hospital clustering into account. To do so, one would 
need to report separate within and between hospital SD. 
Table 4 does not report standard errors.  The table contains descriptive statistics, including standard 
deviations, that show the distribution of index scores over hospitals.   Our statement about standard 
errors is correct.  We have therefore not altered the text or the data in the table.
R4) Not sure what this means (page 6): the case-mix adjusted performance estimates  are 
themselves expressed as index scores.
We have removed this sentence.  It does not add anything to the paper, so there would be no point 
in explaining it.
R5) Page 7: Pearson correlation is not rank correlation. Which is intended Pearson correlation 
or Spearman rank correlation?
Thank you for pointing out this potentially misleading label. The correlations are, as the reviewer 
suggests, Spearman rank correlations. These are Pearson correlations applied to ranked data, but we 
accept that our description is ambiguous, so we have updated the text and Figure 2 accordingly. 
R6) Not sure the information on change in HRQoL at the beginning of Results was anticipated in
Methods.
The start of the results section provides descriptive statistics to familiarise the reader with the data, 
rather than to address a specific research question.  We believe this is consistent with the MDM 
house style for this type of auxiliary information. 
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